Authors: Hirsch, FR Osterlind, K Jeppesen, N Dombernowsky, P Ingeberg, S Sorensen, PG Kristensen, C Hansen, HH

Citation: Fr. Hirsch et al., Superiority of high-dose platinum (cisplatin and carboplatin) compared to carboplatin alone in combination chemotherapy for small-cell lung carcinoma: A prospective randomised trial of 280 consecutive patients, ANN ONCOL, 12(5), 2001, pp. 647-653

Authors: Ryberg, M Nielsen, D Osterlind, K Skovsgaard, T Dombernowsky, P

Citation: M. Ryberg et al., Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapy, ANN ONCOL, 12(1), 2001, pp. 81-87

Authors: Osterlind, K

Citation: K. Osterlind, LDH or NSE or LDH and NSE as pretreatment prognostic factors in small celllung cancer? A commentary, LUNG CANC, 30(1), 2000, pp. 51-53

Authors: Drivsholm, L Paloheimo, LI Osterlind, K

Citation: L. Drivsholm et al., Chromogranin A, a significant prognostic factor in small cell lung cancer, BR J CANC, 81(4), 1999, pp. 667-671

Authors: Lassen, UN Osterlind, K Hirsch, FR Bergman, B Dombernowsky, P Hansen, HH

Citation: Un. Lassen et al., Early death during chemotherapy in patients with small-cell lung cancer: derivation of a prognostic index for toxic death and progression, BR J CANC, 79(3-4), 1999, pp. 515-519